Here is the latest shareholding Pattern of BAL PHARMA. For more details, see the BAL PHARMA financial fact sheet and BAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 47.79 | 47.79 | 47.43 | 47.43 | 47.43 | 47.43 | 47.09 | 47.09 | |
Foreign Promoters | % | 4.21 | 4.21 | 4.18 | 4.18 | 4.18 | 4.18 | 4.15 | 4.15 | |
Total Promoters | % | 52.00 | 52.00 | 51.61 | 51.61 | 51.61 | 51.61 | 51.23 | 51.23 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.30 | 0.20 | 0.18 | 0.00 | 0.17 | 0.14 | 0.13 | 0.13 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.30 | 0.20 | 0.18 | 0.17 | 0.17 | 0.14 | 0.13 | 0.13 | |
Bodies Corporate | % | 0.00 | 0.64 | 0.50 | 0.46 | 0.36 | 0.37 | 0.40 | 0.52 | |
Individuals | % | 31.45 | 31.48 | 32.13 | 32.07 | 31.99 | 32.19 | 32.64 | 32.15 | |
NRIs/OCBs | % | 12.87 | 12.88 | 12.80 | 12.82 | 12.82 | 12.84 | 12.63 | 12.42 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 3.39 | 2.80 | 2.78 | 2.88 | 3.06 | 2.85 | 2.97 | 3.55 | |
Total Non-Institution | % | 47.71 | 47.80 | 48.21 | 48.23 | 48.23 | 48.25 | 48.64 | 48.64 | |
Total Public | % | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 49.00 | 49.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.